CWM
Cahaba Wealth Management Portfolio holdings
AUM
$1.44B
1-Year Est. Return
12.72%
1 Year Est. Return
+12.72%
AUM
$1.38B
AUM Growth
+$94.3M
(+7.3%)
Holding
164
Top Buys
| 1 | +$168M | |
| 2 | +$5.64M | |
| 3 | +$4.19M | |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$2.57M |
| 5 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$2.26M |
Top Sells
| 1 | +$153M | |
| 2 | +$8.5M | |
| 3 | +$1.32M | |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$1.01M |
| 5 |
Southern Company
SO
|
+$710K |
Sector Composition
| 1 | Utilities | 2.62% |
| 2 | Technology | 1.59% |
| 3 | Financials | 1.37% |
| 4 | Industrials | 0.54% |
| 5 | Healthcare | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amgen
AMGN
$173B
| $202K | 0.01% |
716
-140
|
|
||
152
Warner Bros
WBD
$70.2B
| $195K | 0.01% |
+10,002
|
|
||
|
FSCO
153
FS Credit Opportunities Corp
FSCO
$1.27B
| $191K | 0.01% |
27,682
+770
|
|
||
|
TGB
154
Taseko Mines
TGB
$2.34B
| $153K | 0.01% |
36,134
|
|
||
155
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
| $99.3K | 0.01% |
+12,108
|
|
||
156
Galectin Therapeutics
GALT
$195M
| $88.9K | 0.01% |
21,000
|
|
||
157
FibroBiologics
FBLG
$22.3M
| $8.03K | ﹤0.01% |
14,702
|
|
||
158
Schwab US Aggregate Bond ETF
SCHZ
$9.61B
| – | – |
-22,454
|
|
||
159
Vanguard Intermediate-Term Treasury ETF
VGIT
$36.5B
| – | – |
-5,867
|
|
||
160
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.9B
| – | – |
-6,719
|
|
||
161
State Street Health Care Select Sector SPDR ETF
XLV
$41.3B
| – | – |
-1,842
|
|
||
162
Vanguard Total Bond Market
BND
$147B
| – | – |
-17,904
|
|
||
163
Emerson Electric
EMR
$82.3B
| – | – |
-1,664
|
|
||
164
Schwab US Dividend Equity ETF
SCHD
$74.8B
| – | – |
-16,018
|
|